Supplementary Table S2 from Efficacy and Safety of Adagrasib plus Cetuximab in Patients with KRASG12C-Mutated Metastatic Colorectal Cancer
crossref(2024)
Abstract
Table S2. Demographics and baseline characteristics of patients with KRASG12C-mutated unresectable or metastatic CRC receiving adagrasib monotherapy.
MoreTranslated text
AI Read Science
Must-Reading Tree
Example
Generate MRT to find the research sequence of this paper
Chat Paper
Summary is being generated by the instructions you defined